Fluralaner |
![]() Last updated: 16/09/2025 |
![]() |
(Not known by any other names) |
|
![]() |
|
An isoxazoline veterinary medicine administered orally or as a spot-on systemic insecticide and acacide | |
---|---|---|
|
Used for the treatment of fleas, ticks and other parasites in animals | |
|
Dogs; Cats; Poultry; Cattle |
Approval status |
|
Approved - usually supplied as a prescription only medicine to be authorised by a veterinarian (POM-V) | |
---|---|---|
|
Approved |
Chemical structure |
|
Fluralaner exhibits stereoisomerism, specifically existing as a racemic mixture of two enantiomers. These enantiomers arise due to the presence of chiral centres in its complex structure, particularly within its isoxazoline ring system and adjacent substituents. | |
---|---|---|
|
C₂₂H₁₇Cl₂F₆N₃O₃ | |
|
- | |
|
- | |
|
MLBZKOGAMRTSKP-UHFFFAOYSA-N | |
|
- | |
|
Yes |
General status |
|
Insecticide, Acaracide | |
---|---|---|
|
Isoxazoline | |
|
- | |
|
- | |
|
Synthetic | |
|
Inhibits γ-aminobutyric acid (GABA)-gated chloride channels (GABACls) and Glutamate-gated chloride channel (GluCl) allosteric modulator. | |
|
[Ligand-gated chloride channels, Inhibitor] | |
|
864731-61-3 | |
|
- | |
|
- | |
|
- | |
|
- | |
|
Ectoparasiticide for systemic use | |
|
QP53BE02 | |
|
No | |
|
- | |
|
556.29 | |
|
- | |
|
4-(5-(3,5-Dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl)-2-methyl-n-(2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)benzamide | |
|
- | |
|
- | |
|
- | |
|
- | |
|
White to off-white crystals or powder | |
|
Commercial |
|
|
|||
---|---|---|---|---|
|
Current | |||
|
Early 2000s, developed; 2014, global launch; 2015, first approvals EU & UK | |||
|
|
|||
|
|
|||
|
Available as tablets and pour-on products | |||
|
Fluralaner is synthesised through a multi-step organic process involving the construction of its complex isoxazoline-based scaffold. The production begins with key intermediates such as 3,5-dichloro-2,2,2-trifluoroacetophenone and 2-amino-N-(2,2,2-trifluoroethyl)acetamide, which are prepared via controlled halogenation and amide formation reactions. These intermediates undergo condensation, cyclisation, and functional group modifications, including the formation of the isoxazoline ring and the attachment of fluorinated aromatic moieties. | |||
|
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. |
|
![]() |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
3.16 X 1004 | Calculated | - | |||||||
|
4.5 | E4 E = Manufacturers safety data sheets 4 = Verified data |
High | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- |
Degradation |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
60 | E4 E = Manufacturers safety data sheets 4 = Verified data |
Moderately persistent | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
Stable | E4 E = Manufacturers safety data sheets 4 = Verified data |
Stable | |||||||
|
Stable at all environmentally relevant pHs at 25 °C | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
|
- |
Soil adsorption and mobility |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
|
- |
Fate indices |
|
|
|
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||||||||||||||||||||
|
|
27 | E4 E = Manufacturers safety data sheets 4 = Verified data |
Low potential | |||||||||||||||||||||||||
|
No data | - |
Known metabolites |
None
|
![]() |
Terrestrial ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
> 2000 | A5 A = EU regulatory and evaluation data as published by EC, EFSA (RAR, DAR & Conclusion dossiers), EMA (e.g. EU Annex III PIC DGD) (EU - Pesticides database; EFSA Scientific Publications ) Rat5 = Verified data used for regulatory purposes |
Low | ||||||||
|
|
- | - | - | |||||||
|
- | - | |||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
0.13 | R4 R = Peer reviewed scientific publications Apis mellifera4 = Verified data |
High | |||||||
|
0.13 | R4 R = Peer reviewed scientific publications Apis mellifera4 = Verified data |
High | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
- | |||||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - |
Aquatic ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
2.0 | E4 E = Manufacturers safety data sheets Cyprinus carpio4 = Verified data |
Moderate | ||||||||
|
- | - | - | ||||||||
|
> 10.0 | F4 F = U.S. EPA ECOTOX database / U.S. EPA pesticide fate database / Miscellaneous WHO documents / FAO data, IPCS INCHEM data (US EPA Databases Related to Pesticide Risk Assessment ) Danio rerio4 = Verified data |
Moderate | ||||||||
|
> 0.001 | E4 E = Manufacturers safety data sheets Daphnia magna4 = Verified data |
High | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
10 | E4 E = Manufacturers safety data sheets Raphidocelis subcapitata4 = Verified data |
Moderate | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - |
|
- | - | - | |||
|
- | - | - |
|
![]() |
General |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
> 2000 | A5 A = EU regulatory and evaluation data as published by EC, EFSA (RAR, DAR & Conclusion dossiers), EMA (e.g. EU Annex III PIC DGD) (EU - Pesticides database; EFSA Scientific Publications ) Rat5 = Verified data used for regulatory purposes |
Low | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | |||||||||
|
- | ||||||||||
|
Excretion of unchanged fluralaner occurs in faeces (~90% of the dose) | F4 F = U.S. EPA ECOTOX database / U.S. EPA pesticide fate database / Miscellaneous WHO documents / FAO data, IPCS INCHEM data (US EPA Databases Related to Pesticide Risk Assessment ) 4 = Verified data |
- |
Health issues |
|
|
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
May cause serious eye damage May cause breathing difficulties or asthma symptoms Suspected of causing genetic defects May damage vital organs |
Handling issues |
|
|
|||
---|---|---|---|---|
|
No information available | |||
|
Health: H315, H317. H318, H334, H335, H341, H361, H371 Environment: H413 |
|||
|
Not listed (Not listed) | |||
|
Not regulated | |||
|
- | |||
|
- |
|
![]() |
|
|
||
---|---|---|---|
|
fluralaner | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- |
Record last updated: | 16/09/2025 |
Contact: | aeru@herts.ac.uk |
Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |